top of page

IPL (Intense Pulse Light) Dry Eye Treatment, Sydney 

OptiLight intense pulsed light treatment with protective eye shields and coupling gel applied to the skin.

Targeted treatment for dry eye associated with meibomian gland dysfunction

 

Dry, gritty or burning eyes can persist even with regular lubricating drops. For some patients, the problem involves inflammation and poorly functioning oil glands within the eyelids, allowing tears to evaporate too quickly.

 

At Eye and Retina Specialists in Waterloo, Sydney, we offer Lumenis OptiLight Intense Pulsed Light (IPL) treatment for suitable patients with evaporative dry eye associated with meibomian gland dysfunction. Treatment can be combined with meibomian gland expression and other measures selected following assessment of your eyes, eyelids and tear film.

​

What is OptiLight?

 

OptiLight is a light-based treatment system developed by Lumenis for managing dry eye associated with meibomian gland dysfunction. It delivers controlled pulses of light to selected areas of facial skin, including the cheeks beneath the eyes, while the eyes are protected.

 

The system incorporates Optimal Pulse Technology (OPT™), which controls the delivery of light energy. Its larger IPL handpiece also incorporates SapphireCool™ contact cooling to help protect the skin and support comfort during treatment.

 

OptiLight is used as part of an individualised dry-eye treatment plan. The choice of treatment depends on the underlying causes of your symptoms, your examination findings and your suitability for IPL.

​

Close-up of the Lumenis OptiLight treatment system and control screen.

​

How do the meibomian glands affect dry eye?

 

The meibomian glands sit within the upper and lower eyelids and release oil through small openings along the eyelid margins. This oil forms an important part of the tear film, helping tears remain stable between blinks.

 

When gland openings become obstructed or the secretions become thickened, less oil reaches the surface of the eye. Tears may then evaporate more rapidly, contributing to irritation, inflammation and fluctuating vision.

 

Symptoms can include grittiness, burning, redness, intermittent blurred vision, sensitivity to wind or air conditioning, and discomfort during reading, computer use or contact lens wear.

 

Meibomian gland dysfunction can occur alongside blepharitis and ocular rosacea. Some patients also have reduced watery tear production, so more than one component of dry eye may need treatment.

​

How can IPL help?

 

IPL is intended to address inflammatory changes associated with meibomian gland dysfunction. One proposed mechanism involves targeting small abnormal blood vessels in the surrounding facial skin that may contribute to inflammation. Other proposed effects include changes in inflammatory activity and improvement in the quality and flow of gland secretions.

 

In suitable patients, treatment may help improve meibomian gland function and oil secretion, improve tear-film stability, reduce some signs of inflammation and relieve dry-eye symptoms. The response varies between patients.

​

Close-up examination of the eye and lower eyelid under slit-lamp illumination.

​

IPL and meibomian gland expression

 

Meibomian gland expression is an important complementary treatment that may be performed alongside IPL. During expression, controlled pressure is applied to the eyelids to encourage retained oils to leave the gland openings. This allows the clinician to assess the quality of the secretions and help clear obstructed glands.

 

IPL and gland expression have complementary roles: IPL aims to improve the inflammatory environment and gland function, while expression helps release retained secretions.

 

Clinical trials comparing IPL combined with gland expression against gland expression alone have reported greater improvements in tear-film stability and several measures of gland function. Improvements in symptoms have varied between the measures used. Your clinician will determine whether expression is appropriate and how it should be incorporated into your treatment course.

​

Who may benefit from OptiLight?

 

OptiLight may be considered when examination identifies meibomian gland dysfunction contributing to persistent dry-eye symptoms. This can include patients with thickened gland secretions, obstructed gland openings, eyelid inflammation or associated ocular rosacea. It may be an option when lubricating drops, warm compresses and eyelid hygiene have not provided sufficient control.

 

Suitability depends on more than symptoms alone. Your assessment considers skin type, recent tanning or sun exposure, medical conditions, medications, previous procedures and the condition of the skin in the proposed treatment area. Some conditions and medicines that increase sensitivity to light can make IPL unsuitable.

 

An examination is also important to identify other causes of discomfort that may require a different approach.

​

What happens during treatment?

​

Assessment and preparation

 

Before treatment, we assess your symptoms, ocular surface, eyelids and meibomian gland function. Tear-film stability and tear production may also be assessed where indicated. You will be asked about your medical history, medications and recent skin or eye treatments. Preparation instructions will explain skin care, sun precautions and anything you need to avoid before your appointment.

​

The IPL treatment

 

Your skin is prepared, and appropriate protective eye shields are fitted. Coupling gel may be used with the treatment handpiece. A series of controlled light pulses is delivered to selected areas of facial skin beneath and around the eyes. You may notice warmth or a brief stinging sensation with each pulse. Settings are selected according to your skin and treatment requirements.

 

The light-treatment component generally takes around 10–15 minutes. Allow additional time for preparation, assessment and gland expression when this is performed.

​

Meibomian gland expression

 

Where appropriate, the clinician expresses the glands to help release retained oils. The pressure and extent of expression are adjusted according to the examination findings and your tolerance.

​

How many treatments are needed?

 

An initial course commonly involves four sessions, approximately two to four weeks apart. Your treatment schedule is individualised. Progress is assessed using both your symptoms and examination findings, including the quality of gland secretions and tear-film stability.

 

Some patients notice improvement during the course, while others require longer before the response becomes clear. Maintenance treatment may be considered if symptoms or gland dysfunction recur. Dry eye commonly requires ongoing management, so treatment may continue to include lubricating drops, eyelid care or other measures between appointments.

​

Recovery and aftercare

 

Many patients can return to their usual daily activities after treatment. Temporary redness, warmth or mild swelling can occur. Aftercare includes protecting the treated skin from sun exposure and following the recommended sunscreen and skin-care instructions. You will receive advice about exercise, heat exposure, makeup and other facial treatments.

 

Continue your prescribed dry-eye care unless your clinician advises otherwise. Contact the practice if you develop unexpected or persistent symptoms after treatment.

​

Possible risks and side effects

 

Possible side effects include discomfort, redness, swelling, bruising and temporary skin irritation. Pigmentation changes, burns, blistering, scarring and changes in skin texture can also occur. Correct patient selection, treatment settings and eye protection are essential. Your clinician will discuss the risks relevant to your skin, medical history and treatment plan before proceeding.

​

Part of your personalised dry-eye care

 

Dry eye often has several overlapping causes. IPL addresses selected inflammatory and gland-related components, but other contributors may need treatment as well. Depending on your assessment, management may include lubricating drops, warm compresses, eyelid hygiene, treatment of blepharitis, prescription anti-inflammatory therapy or measures to improve tear retention.

 

Blinking patterns, eyelid position, reduced tear production and environmental factors may also need attention. Reviewing these factors helps guide a treatment plan that addresses your particular combination of problems.

​

Frequently asked questions

​

Is IPL a laser treatment?

 

No. IPL uses pulses containing a range of light wavelengths. It differs from the lasers used for vision correction and does not reshape the cornea.

​

Can IPL help when dry eye is associated with rosacea?

 

It may be useful when ocular rosacea is accompanied by meibomian gland dysfunction and eyelid inflammation. Your assessment will determine whether these changes are present and whether IPL is suitable.

​

Will I still need eye drops?

 

Possibly. Lubricating drops and other treatments may remain useful after IPL. The aim is to improve control of your condition; changes to your treatment are guided by your response.

​

Is IPL a permanent cure for dry eye?

 

IPL can improve signs and symptoms in selected patients, but dry eye is often a long-term condition. Ongoing eyelid care, other treatments or maintenance sessions may be needed.

​

Lumenis OptiLight treatment system with handpieces and wheeled console.

​

OptiLight treatment in Waterloo, Sydney

 

Eye and Retina Specialists provides assessment and treatment of dry eye and related eyelid conditions at our Waterloo practice, near Green Square. To arrange an assessment or enquire about OptiLight treatment, contact our reception team.

 

Suite C1, 30–36 O’Dea Avenue, Waterloo NSW 2017

 

Telephone: (02) 9699 0001 | Email: reception@eyeandretina.com.au

 

General information only. Treatment suitability, benefits and risks are assessed individually. Results vary.

 

Read more about dry eye assessment and treatment.

Suite C1, 30-36 O'Dea Avenue
Waterloo NSW 2017

  • YouTube

Disclaimer: Information provided on this site is general in nature, and is intended for educational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis or treatment. Always ask the advice of your physician or other qualified health professional for issues related to your specific situation. Selected images may be digitally enhanced, edited or illustrative content.

 

Eye and Retina Specialists disclaims any or all liability to any party for any direct or indirect, implied, punitive, special or other consequential damage that may arise from any use of the information provided on this website or on any related social media postings, podcasts or radio or television broadcasts.

​

© Eye and Retina Specialists 2013-2026

bottom of page